CPT 82962: Home Blood Glucose Monitoring, Fingerstick

CPT code 82962 covers patient-performed blood glucose monitoring using small electronic, FDA-approved devices (the common “fingerstick” method). This code captures a widely used, high-frequency point-of-care service critical to diabetes self-management and preventive care. Nationally, home blood glucose testing influences ambulatory care workflows, supplies utilization, and short-term clinical decision making for patients with diabetes and related metabolic disorders.

Key payers in the national context include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how 82962 is defined clinically and operationally, common payer coverage considerations, and where this service fits in routine outpatient and home care pathways. The publication summarizes benchmark themes such as utilization patterns, payer coverage scope, and billing considerations relevant to providers, coders, and policy analysts.

The report also provides clinical context for when patient self-testing is used, typical sites of service, and how 82962 interacts with broader diabetes management protocols. Data not available in the input will be identified explicitly in relevant sections.

Billing Code Overview

CPT code 82962 describes blood glucose monitoring performed at home using small electronic devices. The procedure is a patient-performed, point-of-care test—commonly the “fingerstick method”—that provides an immediate blood glucose measurement using FDA-approved devices.

Service Type: Home blood glucose monitoring (patient self-testing)

Typical Site of Service: Patient's home

Clinical Context

A typical patient is a 58-year-old with type 2 diabetes managed with oral agents and/or insulin who performs self-monitoring of blood glucose (SMBG) at home using an FDA‑approved fingerstick glucometer. The clinical workflow begins with the clinician prescribing home blood glucose monitoring and providing education on device use, frequency of checks (for example fasting, pre‑meal, post‑prandial, bedtime), and target ranges. The patient obtains an FDA‑approved meter and test strips, performs a fingerstick, and reads the instantaneous result displayed on the small electronic device. Results are documented in a logbook or transmitted electronically to the clinician when issues arise (hypoglycemia, hyperglycemia, or glycemic variability). The clinician reviews SMBG data during follow‑up visits or remote encounters to adjust medications, counseling, or referrals to diabetes education. Billing for the SMBG device use and test results is captured with 82962 when the patient performs the test themselves using a small electronic device (fingerstick method). Typical site of service is outpatient clinic, physician office, home, or telehealth/remote monitoring contexts where SMBG results are discussed.

Coding Specifications

Modifier	Description	When to Use
`25`	Significant, separately identifiable evaluation and management service by the same physician on the same day	Use when an E/M visit is provided the same day as instruction or interpretation related to SMBG and meets E/M documentation requirements.

Taxonomy Code	Specialty	Notes
`207Q00000X`	Family Medicine	Primary providers who prescribe SMBG and review logs.
`207R00000X`	Internal Medicine	Internists managing diabetes and adjusting therapy based on SMBG.
`208D00000X`	Endocrinology	Specialists who interpret SMBG patterns for insulin titration.
`163W00000X`	Diabetes Educator/Certified Diabetes Care and Education Specialist	Provide SMBG device training and patient education.
`261QM2000X`	Nurse Practitioner	Advanced practice providers who prescribe SMBG and review results.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`E11.9`	Type 2 diabetes mellitus without complications	Most common indication for home blood glucose monitoring to guide therapy.
`E10.9`	Type 1 diabetes mellitus without complications	Indication for frequent SMBG for insulin dosing and hypoglycemia prevention.
`R73.09`	Other abnormal glucose	SMBG may be used to evaluate suspected dysglycemia.
`E11.65`	Type 2 diabetes mellitus with hyperglycemia	SMBG used to identify and manage hyperglycemia.
`E11.64`	Type 2 diabetes mellitus with hypoglycemia	SMBG essential to detect and treat hypoglycemic events.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`82962`	Glucose, blood by glucose monitoring device(s) cleared by the FDA for home use	Primary code for patient-performed home fingerstick glucose testing.
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Commonly billed when SMBG data are reviewed during a routine outpatient follow-up.
`99457`	Remote physiologic monitoring treatment management services, 20 minutes or more of clinical staff/physician/other qualified health care professional time in a calendar month	Used when SMBG data are transmitted and monitored remotely as part of RPM services.
`97802`	Medical nutrition therapy; initial assessment and intervention, individual, 15 minutes	May be performed alongside SMBG instruction when dietary changes are addressed.
`G2012`	Brief communication technology-based service (virtual check-in)	Used for brief patient-initiated communications to review SMBG results (if payer accepts).

OpenPayer

Summary & Overview